Keywords
Documents disponibles dans cette catégorie (343)
sorted by (Issue date descending, Issue date descending, System of projection of the document ascending) | Add the result to the basket | Make a suggestion | Refine your search
Extend search on down-posting(s)
Article
Article
Kaifer KA, Author ; Villalon E ; Osman EY ; Glascock JJ ; Arnold LL ; Cornelison DD ; Lorson CL | 2017Article
Pinard E, Author ; Green L ; Reutlinger M ; Weetall M ; Naryshkin NA ; Baird J ; Chen KS ; Paushkin SV ; Metzger F ; Ratni H | 2017Article
Iyer CC, Author ; Wang X ; Renusch SR ; Duque SI ; Wehr AM ; Mo XM ; McGovern VL ; Arnold WD ; Burghes AH ; Kolb SJ | 2017Article
Adams L, Author | 2017Comment on: Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. [Lancet. 2016]Article
Article
Nash LA, Author ; McFall ER ; Perozzo AM ; Turner M ; Poulin KL ; de Repentigny Y ; Burns JK ; McMillan HJ ; Warman-Chardon J ; Burger D ; Kothary R ; Parks RJ | 2017Article
Mendell JR, Author ; Al Zaidy S ; Shell R ; Arnold WD ; Rodino-Klapac LR ; Prior TW ; Lowes L ; Alfano L ; Berry K ; Church K ; Kissel JT ; Nagendran S ; L'Italien J ; Sproule DM ; Wells C ; Cardenas JA ; Heitzer MD ; Kaspar A ; Corcoran S ; Braun L ; Likhite S ; Miranda C ; Meyer K ; Foust KD ; Burghes AHM ; Kaspar BK | 2017Comment in The Dilemma of Two Innovative Therapies for Spinal Muscular Atrophy. [N Engl J Med. 2017] Motor neuron disease: Positive trial results published for ground-breaking SMA therapies. [Nat Rev Neurol. 2018] Therapy for Spin[...]Article
van der Ploeg AT, Author | 2017Comment on Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. [N Engl J Med. 2017] Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. [N Engl J Med. 2017]Article
Article
5th International Congress of Myology (14-18 March 2016; Centre convention, Lyon, France), Issuing body ; Finkel R, Author ; Mendell J, Author ; Biondi O, Author | AFM-TELETHON | 17/03/2016Article
Kolb SJ, Author ; Coffey CS ; Yankey JW ; Krosschell K ; Arnold WD ; Rutkove SB ; Swoboda KJ ; Reyna SP ; Sakonju A ; Darras BT ; Shell R ; Kuntz N ; Castro D ; Iannaccone ST ; Parsons J ; Connolly AM ; Chiriboga CA ; McDonald C ; Burnette WB ; Werner K ; Thangarajh M ; Shieh PB ; Finanger E ; Cudkowicz ME ; McGovern MM ; McNeil DE ; Finkel R ; Kaye E ; Kingsley A ; Renusch SR ; McGovern VL ; Wang X ; Zaworski PG ; Prior TW ; Burghes AH ; Bartlett A ; Kissel JT | 2016Article
Article
Heesen L, Author ; Peitz M ; Torres-Benito L ; Holker I ; Hupperich K ; Dobrindt K ; Jungverdorben J ; Ritzenhofen S ; Weykopf B ; Eckert D ; Hosseini-Barkooie SM ; Storbeck M ; Fusaki N ; Lonigro R ; Heller R ; Kye MJ ; Brustle O ; Wirth B | 2016Article
Armbruster N, Author ; Lattanzi A ; Jeavons M ; Van Wittenberghe L ; Gjata B ; Marais T ; Martin S ; Vignaud A ; Voit T ; Mavilio F ; Barkats M ; Buj Bello A | 2016Article
Comment on: Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy. [Neurology. 2016]Article
Dimitriadi M, Author ; Derdowski A ; Kalloo G ; Maginnis MS ; O'Hern P ; Bliska B ; Sorkac A ; Nguyen KC ; Cook SJ ; Poulogiannis G ; Atwood WJ ; Hall DH ; Hart AC | 2016Article